Status:
COMPLETED
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Adult Immunoblastic Lymphoma
Central Nervous System Non-Hodgkin Lymphoma
Eligibility:
All Genders
Up to 21 years
Brief Summary
This research study is collecting and storing tissue samples from patients with rare or cutaneous non-Hodgkin lymphoma. Collecting and storing samples of tissue from patients with cancer to test in th...
Detailed Description
OBJECTIVES: I. To determine the clinical features, treatment, and outcome of patients with rare or cutaneous pediatric non-Hodgkin lymphoma (NHL). II. To determine the pathologic and biologic featur...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of NHL
- Any histology, except for Burkitt or Burkitt-like, diffuse large B-cell, anaplastic large cell, or lymphoblastic lymphoma
- Primary CNS, primary cutaneous NHL, or lymphoproliferative diseases of any histology allowed
- Pathological specimen from site not treated within the past 6 months
- Must have specimens available
- At least 6 months since prior chemotherapy irradiation to study lesion
- At least 2 weeks since prior steroids
Exclusion
Key Trial Info
Start Date :
May 30 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT01000753
Start Date
May 30 2005
End Date
September 30 2023
Last Update
October 3 2023
Active Locations (130)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Alabama
Birmingham, Alabama, United States, 35233
2
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States, 35233
3
Phoenix Childrens Hospital
Phoenix, Arizona, United States, 85016
4
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202-3591